Multiple Myeloma Research Foundation (MMRF)

The MMRF accelerates the development and delivery of next-generation therapies, leveraging data to personalize treatment approaches and empower myeloma patients with vital resources. Through over $600 million committed to research, we have initiated nearly 100 clinical trials and facilitated the market introduction of 15+ FDA-approved therapies, tripling the life expectancy of myeloma patients.